Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Pharmaceutical Product Development Stories

2014-02-21 12:25:04

DUBLIN, Ireland, February 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gcm8p2/life_sciences_bpo) has announced the addition of the "Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" [http://www.researchandmarkets.com/research/gcm8p2/life_sciences_bpo ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Economic burden, increased...

2014-02-03 08:23:39

ALBANY, New York, February 3, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Life Sciences BPO Market [Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Risk-Based Monitoring, Clinical Data Management, Biostatistics) and Contract Manufacturing Organizations]- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Life...

2013-12-27 04:21:55

DUBLIN, December 27, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/939k6g/healthcare ) have announced the addition of the "Global Healthcare Contract Research Outsourcing Market - Industry Analysis, Size, Share, Trends And Forecast (2013 - 2018)" [http://www.researchandmarkets.com/research/939k6g/healthcare ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report covers the...

2013-04-29 08:26:45

RALEIGH, N.C., April 29, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced the appointment of Thomas W. D'Alonzo to the company's Board of Directors. Mr. D'Alonzo previously served on the BDSI Board of Directors from August 2006 through June 2008. (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO) "We are very pleased to once again have Tom D'Alonzo as a member of our Board of Directors," said Dr. Frank E. O'Donnell, Jr., Executive Chairman...

2013-01-30 12:26:55

BURLINGTON, Mass., Jan. 30, 2013 /PRNewswire/ -- inVentiv Health, Inc., offering best-in-class clinical, commercial, and consulting services to the healthcare industry, today announced that its existing clinical research organization (CRO), PharmaNet/i3, will be renamed inVentiv Health Clinical. This renaming reflects the closer alignment between the Clinical segment and inVentiv's commercial and consulting services. "As a top global CRO, renaming ourselves inVentiv Health Clinical...

2013-01-22 08:30:30

WILMINGTON, N.C., Jan. 22, 2013 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today the expansion of laboratory service offerings, capabilities and instrumentation in its state-of-the-art laboratory Technology Center in Wilmington, N.C. (Logo: http://photos.prnewswire.com/prnh/20121207/MM26042LOGO) Following the company's opening of its Technology Center in May, 2012, AAIPharma has continued investing...

2012-12-07 16:22:02

WILMINGTON, N.C., Dec. 7, 2012 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today that it has appointed Timothy Rhines, Ph.D., RAC as the company's senior director of biopharmaceutical development for its Wilmington, N.C. laboratory. (Logo: http://photos.prnewswire.com/prnh/20121207/MM26042LOGO) "Tim's focus on customer service and high-quality deliverables makes him a perfect fit for our organization"...

2012-08-22 10:25:10

FARMINGTON, Conn., Aug. 22, 2012 /PRNewswire-iReach/ -- It's a well known data point that while the pills a doctor prescribes may cost pennies each to manufacture, the first pill cost many millions of dollars to research, develop, test, and certify. Along the way, many routes are pursued and ultimately dropped when they fail to yield marketable results. One way drug manufacturers can lower their costs and increase their output is to outsource stages of the process to Contract Research...

2012-08-02 02:29:51

BOSTON, Aug. 2, 2012 /PRNewswire/ -- PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global consultancy serving the biopharmaceutical and medical device industries, today announced that Leanne R. Larson has been appointed as Vice President, Evidence Development. The new position demonstrates a continuing commitment from PAREXEL in the area of Outcomes Research. Ms. Larson's expertise in strategy, design, implementation, and analysis of patient...

2012-05-30 02:26:18

EXTON, Pa., May 30, 2012 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, "Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Studies." The award was presented at the AAPS 2012 National Biotechnology...